Declining rates of inpatient parathyroidectomy for primary hyperparathyroidism in the US

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Kim, Sun Moon ^a   Shu, Aimee D ^a   Long, Jin ^a   Montez Rath, Maria E ^a   Leonard, Mary B ^a   Norton, Jeffrey A ^a   Chertow, Glenn M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL CARE; HOSPITAL COST; HOSPITAL MORTALITY; HOSPITAL PATIENT; HUMAN; ICD-9; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; SEX DIFFERENCE; ADOLESCENT; CHILD; ECONOMICS; HYPERPARATHYROIDISM, PRIMARY; INFANT; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INFANT; INFANT, NEWBORN; INPATIENTS; MALE; MIDDLE AGED; PARATHYROIDECTOMY; UNITED STATES; YOUNG ADULT;

EID: 84984844828     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161192     Document Type: Article

References (38)

1. Heath H, Hodgson SF, Kennedy MA. Primary Hyper-Parathyroidism - Incidence, Morbidity, and Potential Economic-Impact in a Community. New Engl J Med 1980; 302:189-193. PMID: 7350459
2. Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81:2036-2040. PMID: 8964825
3. Bilezikian JP, Silverberg SJ. Clinical practice - Asymptomatic primary hyperparathyroidism. New Engl J Med 2004; 350:1746-1751. PMID: 15103001
4. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New Engl J Med 1999; 341:1249-1255. PMID: 10528034
5. Mollerup CL, Vestergaard P, Frokjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. Brit Med J 2002; 325:807-810. PMID: 12376441
6. Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007; 92:3114-3121. PMID: 17535997
7. Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2004; 89:5415-5422. PMID: 15531491
8. Niederle B, Wemeau JL. Is surgery necessary for 'mild' or 'asymptomatic' hyperparathyroidism? Eur J Endocrinol 2015; 173:D13-20. doi: 10.1530/EJE-15-0277 PMID: 26101370
9. Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Bethesda, Maryland, October 29-31, 1990. J Bone Miner Res 1991; 6 Suppl 2:S1-166.
10. Bilezikian JP, Potts JT, Fuleihan GEH, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century. J Clin Endocr Metab 2002; 87:5353-5361. PMID: 12466320
11. Bilezikian JP, Khan AA, Potts JT, Management TIW. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocr Metab 2009; 94:335-339. doi: 10.1210/jc.2008-1763 PMID: 19193908
12. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. J Clin Endocr Metab 2014; 99:3561-3569. doi: 10.1210/jc.2014-1413 PMID: 25162665
13. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ. The rise and fall of primary hyperparathyroidism: A population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997; 126:433-440. PMID: 9072928
14. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: An update on the changing epidemiology of the disease. J Bone Miner Res 2006; 21:171-177. PMID: 16355286
15. Yeh MW, Wiseman JE, Ituarte PH, Pasternak JD, Hwang RS, Wu B, et al. Surgery for primary hyperparathyroidism: are the consensus guidelines being followed? Ann Surg 2012; 255:1179-1183. doi: 10.1097/SLA.0b013e31824dad7d PMID: 22584631
16. Yeh MW, Ituarte PHG, Zhou HC, Nishimoto S, Liu ILA, Harari A, et al. Incidence and Prevalence of Primary Hyperparathyroidism in a Racially Mixed Population. J Clin Endocr Metab 2013; 98:1122-1129. doi: 10.1210/jc.2012-4022 PMID: 23418315
17. Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone 2015; 73:1-7. doi: 10.1016/j.bone.2014.12.003 PMID: 25497786
18. Agency for Healthcare Research and Quality,The Healthcare cost and utilization project. Introduction to the HCUP nationwide Inpatient Sample (NIS), 2011. Available: https://www.hcup-us.ahrq.gov/db/nation/nis/NIS-Introduction-2011.jsp. Accessed October 14, 2015.
19. Healthcare Cost and Utilization Project (HCUP), Cost-to-charge ratio files. Available: http://www.hcupus. ahrq.gov/db/state/costtocharge.jsp. Accessed October 14, 2015.
20. US Census Bureau. Current Poppulation Survey on Age and Sex. Available: http://www.census.gov/population/age/data/cps.html. Accessed October 15 2015.
21. Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 1998; 47:1-16, 20.
22. Wu BA, Haigh PI, Hwang R, Ituarte PHG, Liu ILA, Hahn TJ, et al. Underutilization of Parathyroidectomy in Elderly Patients with Primary Hyperparathyroidism. J Clin Endocr Metab 2010; 95:4324-4330. doi: 10.1210/jc.2009-2819 PMID: 20610600
23. Stack BC Jr., Spencer H, Moore E, Medvedev S, Bodenner D. Outpatient parathyroid surgery data from the University Health System Consortium. Otolaryngol Head Neck Surg 2012; 147:438-443. doi: 10.1177/0194599812445551 PMID: 22535912
24. Flynn MB, Quayyum M, Goldstein RE, Bumpous JM. Outpatient parathyroid surgery: ten-year experience: is it safe? Am Surg 2015; 81:472-477. PMID: 25975331
25. Sattar N, Welsh P, Panarelli M, Forouhi NG. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012; 379:95-96. doi: 10.1016/S0140-6736(11)61816-3 PMID: 22243814
26. Marcus R, Madvig P, Crim M, Pont A, Kosek J. Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism. Ann Intern Med 1984; 100:633-640. PMID: 6324624
27. McDermott MT, Perloff JJ, Kidd GS. Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. J Bone Miner Res 1994; 9:509-514. PMID: 8030438
28. Khan A, Grey A, Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009; 94:373-381. doi: 10.1210/jc.2008-1762 PMID: 19193912
29. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333. PMID: 12117397
30. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004; 140:184-188. PMID: 14757616
31. Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res 2006; 21:765-771. PMID: 16734392
32. Jha S, Wang Z, Laucis N, Bhattacharyya T. Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996-2012: An Ecological Analysis. J Bone Miner Res 2015
33. Silverberg SJ, Bone HG, Marriott TB, Locker FG, ThysJacobs S, Dziem G, et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. New Engl J Med 1997; 337:1506-1510. PMID: 9366582
34. Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocr Metab 2003; 88:5644-5649. PMID: 14671147
35. Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocr Metab 2005; 90:135-141. PMID: 15522938
36. Marcocci C, Chanson P, Shoback D, Bilezikian J, Fernandez-Cruz L, Orgiazzi J, et al. Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism. J Clin Endocr Metab 2009; 94:2766-2772. doi: 10.1210/jc.2008-2640 PMID: 19470620
37. Thomas DC, Roman SA, Sosa JA. Parathyroidectomy in the elderly: analysis of 7313 patients. J Surg Res 2011; 170:240-246. doi: 10.1016/j.jss.2011.03.014 PMID: 21571309
38. Kim SM, Long J, Montez-Rath ME, Leonard MB, Norton JA, Chertow GM. Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States. Clin J Am Soc Nephrol. 2016; 11:1260-1267. doi: 10.2215/CJN.10370915 PMID: 27269300